Page last updated: 2024-08-16

phenylpropanolamine and Bladder Diseases

phenylpropanolamine has been researched along with Bladder Diseases in 58 studies

Research

Studies (58)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (5.17)	18.7374
1990's	9 (15.52)	18.2507
2000's	45 (77.59)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (1.72)	2.80

Authors

Authors	Studies
Deo, A; Dhamala, JN; Pradhan, T; Yadav, SK	1
Newman, DK	1
Appell, RA	1
Appell, RA; Boone, TB; Lai, HH	1
Staskin, DR	1
Kelleher, CJ; Okano, GJ; Pleil, AM; Reese, PR	1
Burgess, SM; Kelleher, CJ; Kreder, KJ; Pleil, AM; Reese, PR	1
Dimpfl, T; Garely, A; Payne, C; Swift, S	1
Blaakaer, J; Høye, K; Mattiasson, A; Wein, AJ	1
Freeman, R; Hill, S; Millard, R; Slack, M; Sutherst, J	1
Bang, LM; Easthope, SE; Perry, CM	1
Rovner, ES; Wein, AJ	2
Homma, Y; Kawabe, K; Lee, JG; Paick, JS	1
MacDiarmid, SA	1
Malone-Lee, J; Wagg, A	1
Araño, P; Bosch, JL; Chapple, CR; De Ridder, D; Kramer, AE; Ridder, AM	1
Millard, RJ	1
Dehoorne, J; Hoebeke, P; Raes, A; Segaert, I; Van Laecke, E; Vande Walle, J	1
Al-Shukri, S; Chapple, CR; Everaert, K; Huang, M; Meffan, P; Rechberger, T; Ridder, A	1
Caffaratti Sfulcini, J; de la Peña, E; Garat Barredo, JM	1
Caro, JJ; El-Hadi, W; Getsios, D; Ishak, KJ; Payne, K	1
Homma, Y; Uemura, S	1
Chen, Q; Huang, Y; Lu, J; Wang, Y; Xue, W	1
Agarwal, A; Dhiraaj, S; Gupta, D; Kapoor, R; Pandey, CK; Raza, M; Singh, PK; Singh, U; Singhal, V; Srivastava, A	1
Agarwal, A; Dhiraaj, S; Kapoor, R; Singhal, V; Tandon, M	1
Moen, M; Stien, R	1
Bissada, NK; Finkbeiner, AE	1
Höfner, K; Holmdahl, TH; Jonas, U; Madersbacher, H	1
Brynne, N; Edlund, PO; Gabrielsson, J; Hallén, B; Höglund, P; Palmér, L; Stahl, MM	1
Jönsson, L; Kobelt, G; Mattiasson, A	1
Bertilsson, L; Böttiger, Y; Brynne, N; Hallén, B	1
Messelink, EJ	1
Hallén, B; Larsson, G; Nilvebrant, L	1
Kirchberger, I; Kobelt, G; Malone-Lee, J	1
Morgenstern, NE; Ruscin, JM	1
Chapple, CR	1
Doi, T; Imai, S; Kamo, I; Okanishi, S	1
Mitova, E	1
Jonas, U; Kreder, K; Van Kerrebroeck, P; Wein, A; Zinner, N	1
Olsson, B; Szamosi, J	1
Golomb, J	1
Nilvebrant, L	1
Abrams, P; Jacquetin, B; Jonas, U; Malone-Lee, J; Tammela, T; Wein, A; Wyndaele, JJ	1
Hartnett, NM; Saver, BG	1
Jacquetin, B; Wyndaele, J	1
Weiss, BD	1
Huang, RR; Peters, KM	1
Jonas, U; Truss, MC; Wefer, J	1
Abrams, P	1
Cannon, TW; Chancellor, MB	1
Kausar, SA	1
Lama, D; Seidman, LS; Siami, P	1
Mattiasson, A; Stanton, SL; Zinner, NR	1
Ballard, CA; Bergman, A; Koonings, PP	1

Reviews

13 review(s) available for phenylpropanolamine and Bladder Diseases

Article	Year
Pharmacologic treatment for detrusor overactivity. Current urology reports, 2002, Volume: 3, Issue:5 Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders	2002
Update on overactive bladder: pharmacologic approaches on the horizon. Current urology reports, 2003, Volume: 4, Issue:5 Topics: Administration, Cutaneous; Administration, Intravesical; Administration, Oral; Adrenergic beta-3 Receptor Antagonists; Benzhydryl Compounds; Benzilates; Benzofurans; Botulinum Toxins; Cresols; Dosage Forms; Dose-Response Relationship, Drug; Drug Compounding; Drug Evaluation; Duloxetine Hydrochloride; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Thiophenes; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urination Disorders	2003
Overactive bladder: improving the efficacy of anticholinergics by dose escalation. Current urology reports, 2003, Volume: 4, Issue:6 Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Patient Compliance; Patient Satisfaction; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urination Disorders	2003
Treatment of the overactive bladder with tolterodine, a new muscarinic receptor antagonist. BJU international, 1999, Volume: 83 Suppl 2 Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders	1999
Review. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine. BJU international, 1999, Volume: 83, Issue:6 Topics: Adult; Aged; Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence	1999
Tolterodine use for symptoms of overactive bladder. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:10 Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence	1999
Muscarinic receptor antagonists in the treatment of overactive bladder. Urology, 2000, Volume: 55, Issue:5A Suppl Topics: Benzhydryl Compounds; Benzofurans; Clinical Trials as Topic; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence	2000
[Treatment of the overactive bladder with detrusitol]. Harefuah, 2000, Volume: 139, Issue:11-12 Topics: Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders	2000
Clinical experiences with tolterodine. Life sciences, 2001, Apr-27, Volume: 68, Issue:22-23 Topics: Animals; Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases	2001
Tolterodine: an overview. World journal of urology, 2001, Volume: 19, Issue:5 Topics: Animals; Benzhydryl Compounds; Cats; Cresols; Delayed-Action Preparations; Guinea Pigs; Humans; In Vitro Techniques; Mice; Muscarinic Antagonists; Phenylpropanolamine; Rats; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases	2001
Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladder. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:10 Topics: Animals; Benzhydryl Compounds; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cresols; Humans; Intestinal Absorption; Muscarinic Antagonists; Organ Specificity; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases	2001
Pharmacotherapy of the overactive bladder and advances in drug delivery. Clinical obstetrics and gynecology, 2002, Volume: 45, Issue:1 Topics: Administration, Intravesical; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Botulinum Toxins; Capsaicin; Cholinergic Antagonists; Cresols; Cystitis, Interstitial; Diterpenes; Humans; Mandelic Acids; Neurotoxins; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases; Urination Disorders	2002
Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. European urology, 2002, Volume: 41, Issue:1 Topics: Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence	2002

Trials

23 trial(s) available for phenylpropanolamine and Bladder Diseases

Article	Year
Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. The American journal of managed care, 2002, Volume: 8, Issue:19 Suppl Topics: Aged; Australia; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Europe; Female; Health Services Research; Humans; Male; Middle Aged; Muscarinic Antagonists; New Zealand; Phenylpropanolamine; Placebos; Quality of Life; Russia; Tolterodine Tartrate; United States; Urinary Bladder Diseases; Urination Disorders	2002
Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. The American journal of managed care, 2002, Volume: 8, Issue:19 Suppl Topics: Aged; Australia; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Europe; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; New Zealand; Phenylpropanolamine; Quality of Life; Russia; Surveys and Questionnaires; Tolterodine Tartrate; United States; Urinary Bladder Diseases; Urination Disorders	2002
A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder. International urogynecology journal and pelvic floor dysfunction, 2003, Volume: 14, Issue:1 Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence	2003
Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU international, 2003, Volume: 91, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Retention	2003
Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine. Obstetrics and gynecology, 2003, Volume: 102, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Confidence Intervals; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Odds Ratio; Patient Satisfaction; Phenylpropanolamine; Probability; Reference Values; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence; Urination Disorders	2003
Transdermal oxybutynin: for overactive bladder. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Exanthema; Humans; Mandelic Acids; Middle Aged; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia	2003
Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial. BJU international, 2003, Volume: 92, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence; Urination	2003
Pressure-flow variables in patients treated with tolterodine for detrusor overactivity. BJU international, 2003, Volume: 92, Issue:9 Topics: Benzhydryl Compounds; Cresols; Humans; Medical Records; Muscarinic Antagonists; Phenylpropanolamine; Pressure; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urination Disorders; Urodynamics	2003
Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study. BJU international, 2004, Volume: 93, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Retention; Urination	2004
Clinical efficacy of tolterodine with or without a simplified pelvic floor exercise regimen. Neurourology and urodynamics, 2004, Volume: 23, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Exercise Therapy; Female; Humans; Middle Aged; Muscarinic Antagonists; Muscle Hypertonia; Pelvic Floor; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urodynamics	2004
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU international, 2004, Volume: 93, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urination Disorders	2004
The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Anesthesia and analgesia, 2005, Volume: 101, Issue:4 Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Catheterization	2005
Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. British journal of anaesthesia, 2006, Volume: 96, Issue:3 Topics: Adult; Anti-Infective Agents, Urinary; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Intraoperative Care; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nephrostomy, Percutaneous; Phenylpropanolamine; Postoperative Complications; Prospective Studies; Severity of Illness Index; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Catheterization; Urinary Incontinence	2006
Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group. World journal of urology, 1997, Volume: 15, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Placebos; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Urodynamics	1997
Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity. International journal of clinical pharmacology and therapeutics, 1997, Volume: 35, Issue:7 Topics: Adult; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Reference Values; Tolterodine Tartrate; Urinary Bladder Diseases	1997
Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole. British journal of clinical pharmacology, 1999, Volume: 47, Issue:2 Topics: Adult; Anti-Ulcer Agents; Antihypertensive Agents; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Cresols; Cross-Over Studies; Cytochromes; Debrisoquin; Drug Interactions; Humans; Male; Muscarinic Antagonists; Omeprazole; Phenylpropanolamine; Polymorphism, Genetic; Tolterodine Tartrate; Urinary Bladder Diseases	1999
Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data. Urology, 1999, Volume: 53, Issue:5 Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urodynamics	1999
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology, 2001, Volume: 57, Issue:3 Topics: Administration, Oral; Adult; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Urination Disorders	2001
Food does not influence the pharmacokinetics of a new extended release formulation of tolterodine for once daily treatment of patients with overactive bladder. Clinical pharmacokinetics, 2001, Volume: 40, Issue:2 Topics: Adult; Benzhydryl Compounds; Biological Availability; Cresols; Cross-Over Studies; Delayed-Action Preparations; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases	2001
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine. Drugs & aging, 2001, Volume: 18, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases	2001
Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder. European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 98, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Belgium; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; France; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Placebos; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Urination; Urine	2001
A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: the speed of onset of therapeutic assessment trial (STAT). Clinical therapeutics, 2002, Volume: 24, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Compliance; Phenylpropanolamine; Prospective Studies; Time Factors; Tolterodine Tartrate; Urinary Bladder Diseases; Urination	2002
Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients. Journal of the American Geriatrics Society, 2002, Volume: 50, Issue:5 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia	2002

Other Studies

22 other study(ies) available for phenylpropanolamine and Bladder Diseases

Article	Year
Patient Perception of Bladder Condition after Treatment with Solifenacin and Tolterodine in Overactive Bladder Patients. Journal of Nepal Health Research Council, 2023, Mar-10, Volume: 20, Issue:3 Topics: Benzhydryl Compounds; Cresols; Cross-Sectional Studies; Humans; Nepal; Perception; Phenylpropanolamine; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder, Overactive	2023
New treatment options for overactive bladder and incontinence. Director (Cincinnati, Ohio), 2002,Summer, Volume: 10, Issue:3 Topics: Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Geriatric Assessment; Geriatric Nursing; Humans; Mandelic Acids; Muscarinic Antagonists; Nurse's Role; Nursing Assessment; Nursing Homes; Phenylpropanolamine; Prevalence; Toilet Training; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence	2002
Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial. Current urology reports, 2002, Volume: 3, Issue:5 Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders	2002
Methodologic shortcomings inherent in a post-hoc analysis. Current urology reports, 2002, Volume: 3, Issue:6 Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Tartrates; Tolterodine Tartrate; Urinary Bladder Diseases	2002
Oxybutynin transdermal (Oxytrol) for overactive bladder. The Medical letter on drugs and therapeutics, 2003, May-12, Volume: 45, Issue:1156 Topics: Administration, Cutaneous; Administration, Oral; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Xerostomia	2003
Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder. European urology, 2004, Volume: 45, Issue:2 Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Female; Follow-Up Studies; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Retrospective Studies; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders	2004
[Treatment of bladder instability (non-neurogenic hyperactive bladder) in children, with tolterodine]. Actas urologicas espanolas, 2004, Volume: 28, Issue:2 Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Female; Humans; Male; Muscarinic Antagonists; Phenylpropanolamine; Retrospective Studies; Tolterodine Tartrate; Urinary Bladder Diseases	2004
Canadian economic comparison of extended-release oxybutynin and immediate-release tolterodine in the treatment of overactive bladder. Clinical therapeutics, 2004, Volume: 26, Issue:3 Topics: Benzhydryl Compounds; Canada; Costs and Cost Analysis; Cresols; Delayed-Action Preparations; Female; Humans; Male; Mandelic Acids; Markov Chains; Middle Aged; Models, Economic; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases	2004
Use of the short form of King's Health Questionnaire to measure quality of life in patients with an overactive bladder. BJU international, 2004, Volume: 93, Issue:7 Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Reproducibility of Results; Surveys and Questionnaires; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence	2004
[Tolterodine for bladder spasm caused by the indwelling catheter after prostate operation]. Zhonghua nan ke xue = National journal of andrology, 2004, Volume: 10, Issue:5 Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Catheters, Indwelling; Cresols; Humans; Male; Middle Aged; Phenylpropanolamine; Spasm; Tolterodine Tartrate; Transurethral Resection of Prostate; Urinary Bladder Diseases; Urinary Catheterization	2004
Urge incontinence. Annales chirurgiae et gynaecologiae, 1982, Volume: 71, Issue:4 Topics: Central Nervous System Diseases; Cystitis; Female; Genital Diseases, Female; Humans; Male; Phenylpropanolamine; Pressure; Urethra; Urethritis; Urinary Bladder; Urinary Bladder Diseases; Urinary Incontinence	1982
Drug therapy for lower urinary tract dysfunction. The Urologic clinics of North America, 1980, Volume: 7, Issue:1 Topics: Bethanechol Compounds; Ephedrine; Female; Humans; Male; Parasympatholytics; Phenoxybenzamine; Phenylpropanolamine; Urinary Bladder; Urinary Bladder Diseases	1980
Tolterodine for overactive bladder. The Medical letter on drugs and therapeutics, 1998, Oct-23, Volume: 40, Issue:1038 Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Double-Blind Method; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders; Xerostomia	1998
Cost-effectiveness of new treatments for overactive bladder: the example of tolterodine, a new muscarinic agent: a Markov model. Neurourology and urodynamics, 1998, Volume: 17, Issue:6 Topics: Benzhydryl Compounds; Cohort Studies; Cost-Benefit Analysis; Cresols; Drug Costs; Humans; Markov Chains; Muscarinic Antagonists; Phenylpropanolamine; Sensitivity and Specificity; Tolterodine Tartrate; Urinary Bladder Diseases	1998
Possible site of action of TAK-637, a tachykinin NK(1) receptor antagonist, on the micturition reflex in guinea pigs. European journal of pharmacology, 2000, Aug-04, Volume: 401, Issue:2 Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Carbachol; Cresols; Denervation; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Humans; In Vitro Techniques; Male; Mandelic Acids; Muscle Contraction; Naphthyridines; Pelvis; Phenylpropanolamine; Reflex; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases	2000
[Detrusitol - a drug of choice in impaired function of the bladder and urinary incontinence]. Akusherstvo i ginekologiia, 2000, Volume: 39 Suppl 2 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia	2000
Detrol LA and Diropan XL for overactive bladder. The Medical letter on drugs and therapeutics, 2001, Apr-02, Volume: 43, Issue:1101 Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Female; Headache; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders; Xerostomia	2001
Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder? The Journal of family practice, 2001, Volume: 50, Issue:7 Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Phenylpropanolamine; Prospective Studies; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence	2001
POEMS (patient-oriented evidence that matters) spark discussion. The Journal of family practice, 2001, Volume: 50, Issue:10 Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Evidence-Based Medicine; Humans; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence	2001
Tolterodine once-daily in treatment of the overactive bladder. Urology, 2001, Volume: 58, Issue:5 Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders	2001
Tolterodine: a safe and effective treatment for older patients with overactive bladder. Journal of the American Geriatrics Society, 2002, Volume: 50, Issue:4 Topics: Aged; Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases	2002
Detrusor instability. Is the bladder the cause or the effect? The Journal of reproductive medicine, 1989, Volume: 34, Issue:10 Topics: Adult; Female; Humans; Middle Aged; Parasympatholytics; Phenylpropanolamine; Prospective Studies; Urethral Diseases; Urinary Bladder Diseases; Urodynamics	1989